Literature DB >> 21403390

Microglia demonstrate age-dependent interaction with amyloid-β fibrils.

Angela Marie Floden1, Colin Kelly Combs.   

Abstract

Alzheimer's disease (AD) is an age-associated disease characterized by increased accumulation of extracellular amyloid-β (Aβ) plaques within the brain. Histological examination has also revealed profound microglial activation in diseased brains often in association with these fibrillar peptide aggregates. The paradoxical presence of increased, reactive microglia yet accumulating extracellular debris suggests that these cells may be phagocytically compromised during disease. Prior work has demonstrated that primary microglia from adult mice are unable to phagocytose fibrillar Aβ1-42 in vitro when compared to microglia cultured from early postnatal animals. These data suggest that microglia undergo an age-associated decrease in microglial ability to interact with Aβ fibrils. In order to better define a temporal profile of microglia-Aβ interaction, acutely isolated, rather than cultured, microglia from 2 month, 6 month, and postnatal day 0 C57BL/6 mice were compared. Postnatal day 0 microglia demonstrated a CD47 dependent ability to phagocytose Aβ fibrils that was lost by 6 months. This corresponded with the ability of postnatal day 0 but not adult microglia to decrease Aβ immunoreactive plaque load from AD sections in vitro. In spite of limited Aβ uptake ability, adult microglia had functional phagocytic uptake of bacterial bioparticles and demonstrated the ability to adhere to both Aβ plaques and in vitro fibrillized Aβ. These data demonstrate a temporal profile of specifically Aβ-microglia interaction with a critical developmental period at 6 months in which cells remain able to interact with Aβ fibrils but lose their ability to phagocytose it.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403390      PMCID: PMC3295838          DOI: 10.3233/JAD-2011-101014

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  74 in total

1.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Authors:  M Stalder; A Phinney; A Probst; B Sommer; M Staufenbiel; M Jucker
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Microglial activation in early stages of amyloid beta protein deposition.

Authors:  A Sasaki; H Yamaguchi; A Ogawa; S Sugihara; Y Nakazato
Journal:  Acta Neuropathol       Date:  1997-10       Impact factor: 17.088

3.  Mature microglia resemble immature antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Glia       Date:  1998-01       Impact factor: 7.452

4.  CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.

Authors:  Kirk P Townsend; Terrence Town; Takashi Mori; Lih-Fen Lue; Doug Shytle; Paul R Sanberg; David Morgan; Francisco Fernandez; Richard A Flavell; Jun Tan
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

5.  Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  Acta Neuropathol       Date:  1998-03       Impact factor: 17.088

6.  Rat microglia exhibit increased density on Alzheimer's plaques in vitro.

Authors:  S N Joshi; K A Crutcher
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

7.  Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

Authors:  Jessica Koenigsknecht; Gary Landreth
Journal:  J Neurosci       Date:  2004-11-03       Impact factor: 6.167

8.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

9.  Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia.

Authors:  K K Kopec; R T Carroll
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

10.  Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells.

Authors:  J G Schulz; D Megow; R Reszka; A Villringer; K M Einhäupl; U Dirnagl
Journal:  Eur J Neurosci       Date:  1998-06       Impact factor: 3.386

View more
  70 in total

Review 1.  Impact of prenatal immune system disturbances on brain development.

Authors:  Amrita Madhusudan; Prisca Vogel; Irene Knuesel
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-13       Impact factor: 4.147

2.  Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

Authors:  Juan E Tichauer; Betsi Flores; Bernardita Soler; Laura Eugenín-von Bernhardi; Gigliola Ramírez; Rommy von Bernhardi
Journal:  Brain Behav Immun       Date:  2013-12-29       Impact factor: 7.217

3.  CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release.

Authors:  Sanjib Karki; Michael R Nichols
Journal:  Biochem Biophys Res Commun       Date:  2014-10-22       Impact factor: 3.575

Review 4.  Roles of microglia in brain development, tissue maintenance and repair.

Authors:  Mackenzie A Michell-Robinson; Hanane Touil; Luke M Healy; David R Owen; Bryce A Durafourt; Amit Bar-Or; Jack P Antel; Craig S Moore
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

Review 5.  Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.

Authors:  Khalil S Rawji; Manoj K Mishra; Nathan J Michaels; Serge Rivest; Peter K Stys; V Wee Yong
Journal:  Brain       Date:  2016-01-29       Impact factor: 13.501

Review 6.  Microglia and Monocyte-Derived Macrophages in Stroke.

Authors:  Eunhee Kim; Sunghee Cho
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 7.  Microglial dysfunction in brain aging and Alzheimer's disease.

Authors:  Kira Irving Mosher; Tony Wyss-Coray
Journal:  Biochem Pharmacol       Date:  2014-01-18       Impact factor: 5.858

Review 8.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

Review 9.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

10.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.